{"transactions":[{"id":1679757,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":95223,"kind":"person","name":"Zhang Yan","position":1,"cik":"0001975257","reported_name":"Zhang Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-12T22:13:24.000Z","date":"2024-01-12","kind":"sale","planned":false,"acquired":false,"shares":104,"price":0.0385,"value":4.004,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-002231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224002231/ownership.xml","form_type":"4"}},{"id":1700639,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-22T21:05:30.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":10,"price":0.621,"value":6.21,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-045912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000149315223045912/ownership.xml","form_type":"4"}},{"id":1900997,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-08T16:05:19.000Z","date":"2022-12-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/18/2022."}],"balance_after":24065,"source":{"system":"sec-edgar","filing":"0001493152-23-015782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000149315223015782/ownership.xml","form_type":"5"}},{"id":1913251,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-26T20:50:00.000Z","date":"2022-12-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/18/2022."}],"balance_after":186722,"source":{"system":"sec-edgar","filing":"0001251371-23-000002","document":"wf-form4_168255658655192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000125137123000002/wf-form4_168255658655192.xml","form_type":"4"}},{"id":2251046,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T08:55:25.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":141000,"price":0.3525,"value":49702.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions and the price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":236722,"source":{"system":"sec-edgar","filing":"0001618835-22-000130","document":"wf-form4_165400171064865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000130/wf-form4_165400171064865.xml","form_type":"4"}},{"id":2278984,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127524,"kind":"person","name":"O'Brien Anthony Stephen","position":1,"cik":"0001726732","reported_name":"O'Brien Anthony Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-06T20:10:43.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Mr. O'Brien's board and committee services."}],"balance_after":6000,"derivative":{"exercise_price":2.47,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001618835-22-000107","document":"wf-form4_165186782403107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883522000107/wf-form4_165186782403107.xml","form_type":"4"}},{"id":2279028,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-06T20:10:20.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Dr. Kamdar's board and committee services."}],"balance_after":6000,"derivative":{"exercise_price":2.47,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001618835-22-000106","document":"wf-form4_165186780339870.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000161883522000106/wf-form4_165186780339870.xml","form_type":"4"}},{"id":2278983,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-06T20:09:27.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Dr. Rarick's board and committee services."}],"balance_after":6000,"derivative":{"exercise_price":2.47,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001618835-22-000104","document":"wf-form4_165186773034453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883522000104/wf-form4_165186773034453.xml","form_type":"4"}},{"id":2279369,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127534,"kind":"person","name":"Rutherford Colin","position":1,"cik":"0001726264","reported_name":"Rutherford Colin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-06T16:09:58.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Mr. Rutherford's board and committee services."}],"balance_after":6000,"derivative":{"exercise_price":2.47,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001618835-22-000105","document":"wf-form4_165186777622176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726264/000161883522000105/wf-form4_165186777622176.xml","form_type":"4"}},{"id":2279367,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127533,"kind":"person","name":"Greer Gillian","position":1,"cik":"0001726181","reported_name":"Greer Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-06T16:08:11.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Dr. Greer's board and committee services."}],"balance_after":6000,"derivative":{"exercise_price":2.47,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001618835-22-000103","document":"wf-form4_165186767214509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726181/000161883522000103/wf-form4_165186767214509.xml","form_type":"4"}},{"id":2377635,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2022-02-23T16:08:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022."}],"balance_after":300000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001618835-22-000031","document":"wf-form4_164565046081887.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000031/wf-form4_164565046081887.xml","form_type":"4"}},{"id":2377634,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-02-23T16:08:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022."}],"balance_after":516422,"source":{"system":"sec-edgar","filing":"0001618835-22-000031","document":"wf-form4_164565046081887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000031/wf-form4_164565046081887.xml","form_type":"4"}},{"id":2378735,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-02-23T16:06:54.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022."}],"balance_after":450000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001618835-22-000030","document":"wf-form4_164565040087112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883522000030/wf-form4_164565040087112.xml","form_type":"4"}},{"id":2378734,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-23T16:06:54.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022."}],"balance_after":810982,"source":{"system":"sec-edgar","filing":"0001618835-22-000030","document":"wf-form4_164565040087112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883522000030/wf-form4_164565040087112.xml","form_type":"4"}},{"id":2377865,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-02-23T16:04:48.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022."}],"balance_after":750000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001618835-22-000028","document":"wf-form4_164565026543618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000028/wf-form4_164565026543618.xml","form_type":"4"}},{"id":2377864,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-23T16:04:48.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022."}],"balance_after":1435837,"source":{"system":"sec-edgar","filing":"0001618835-22-000028","document":"wf-form4_164565026543618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000028/wf-form4_164565026543618.xml","form_type":"4"}},{"id":2447760,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T16:06:28.000Z","date":"2021-12-31","kind":"disposition_to_issuer","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/3/2021."}],"balance_after":216422,"source":{"system":"sec-edgar","filing":"0001618835-22-000006","document":"wf-form4_164133035440575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000006/wf-form4_164133035440575.xml","form_type":"4"}},{"id":2449575,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:05:20.000Z","date":"2021-12-31","kind":"disposition_to_issuer","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/3/2021."}],"balance_after":360982,"source":{"system":"sec-edgar","filing":"0001618835-22-000005","document":"wf-form4_164133028601106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883522000005/wf-form4_164133028601106.xml","form_type":"4"}},{"id":2447979,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:03:56.000Z","date":"2021-12-31","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/3/2021."}],"balance_after":685837,"source":{"system":"sec-edgar","filing":"0001618835-22-000004","document":"wf-form4_164133021790367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000004/wf-form4_164133021790367.xml","form_type":"4"}},{"id":2463579,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-12-20T16:20:47.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":25000,"price":0.389,"value":9725.0,"ownership":{"direct":true},"balance_after":336422,"source":{"system":"sec-edgar","filing":"0001618835-21-000273","document":"wf-form4_164003523317319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000273/wf-form4_164003523317319.xml","form_type":"4"}},{"id":2463982,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T16:20:04.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":40594,"price":0.37,"value":15019.78,"ownership":{"direct":true},"balance_after":480982,"source":{"system":"sec-edgar","filing":"0001618835-21-000272","document":"wf-form4_164003518854810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883521000272/wf-form4_164003518854810.xml","form_type":"4"}},{"id":2463648,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-20T16:19:18.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":135000,"price":0.375,"value":50625.0,"ownership":{"direct":true},"balance_after":985837,"source":{"system":"sec-edgar","filing":"0001618835-21-000271","document":"wf-form4_164003514607858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000271/wf-form4_164003514607858.xml","form_type":"4"}},{"id":2636717,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-07-09T20:02:10.000Z","date":"2021-07-08","kind":"tax_withholding","acquired":false,"shares":19998,"price":0.975,"value":19498.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 8, 2021. No shares were sold in connection with this transaction."}],"balance_after":448554,"source":{"system":"sec-edgar","filing":"0001618835-21-000158","document":"wf-form4_162586090669169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000158/wf-form4_162586090669169.xml","form_type":"4"}},{"id":2660184,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T21:22:36.000Z","date":"2021-06-18","kind":"purchase","acquired":true,"shares":10000,"price":1.165,"value":11650.0,"ownership":{"direct":true},"balance_after":19287,"source":{"system":"sec-edgar","filing":"0001618835-21-000156","document":"wf-form4_162431053523492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000161883521000156/wf-form4_162431053523492.xml","form_type":"4"}},{"id":2669634,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T20:14:15.000Z","date":"2021-06-11","kind":"purchase","acquired":true,"shares":5000,"price":1.198,"value":5990.0,"ownership":{"direct":true},"balance_after":10250,"source":{"system":"sec-edgar","filing":"0001618835-21-000154","document":"wf-form4_162370163135768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000154/wf-form4_162370163135768.xml","form_type":"4"}},{"id":2669633,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127524,"kind":"person","name":"O'Brien Anthony Stephen","position":1,"cik":"0001726732","reported_name":"O'Brien Anthony Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T20:13:49.000Z","date":"2021-06-14","kind":"purchase","acquired":true,"shares":8140,"price":1.31,"value":10663.4,"ownership":{"direct":true},"balance_after":8140,"source":{"system":"sec-edgar","filing":"0001618835-21-000153","document":"wf-form4_162370161055578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000153/wf-form4_162370161055578.xml","form_type":"4"}},{"id":2671300,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-06-12T00:19:55.000Z","date":"2021-06-11","kind":"purchase","acquired":true,"shares":18180,"price":1.14,"value":20725.2,"ownership":{"direct":true},"balance_after":468552,"source":{"system":"sec-edgar","filing":"0001618835-21-000150","document":"wf-form4_162345718004725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000150/wf-form4_162345718004725.xml","form_type":"4"}},{"id":2674037,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-10T19:30:33.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":24500,"price":1.03,"value":25235.0,"ownership":{"direct":true},"balance_after":440388,"source":{"system":"sec-edgar","filing":"0001618835-21-000148","document":"wf-form4_162336780990730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883521000148/wf-form4_162336780990730.xml","form_type":"4"}},{"id":2673598,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-10T19:30:07.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":50000,"price":1.03,"value":51500.0,"ownership":{"direct":true},"balance_after":850837,"source":{"system":"sec-edgar","filing":"0001618835-21-000147","document":"wf-form4_162336778417446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000147/wf-form4_162336778417446.xml","form_type":"4"}},{"id":2673480,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-06-10T19:29:40.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":10000,"price":1.025,"value":10250.0,"ownership":{"direct":true},"balance_after":311422,"source":{"system":"sec-edgar","filing":"0001618835-21-000146","document":"wf-form4_162336776279756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000146/wf-form4_162336776279756.xml","form_type":"4"}},{"id":2700238,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-21T20:26:39.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":31480,"price":0.86,"value":27072.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":450372,"source":{"system":"sec-edgar","filing":"0001618835-21-000136","document":"wf-form4_162162878492815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000136/wf-form4_162162878492815.xml","form_type":"4"}},{"id":2700237,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-21T20:26:20.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":42061,"price":0.86,"value":36172.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":273390,"source":{"system":"sec-edgar","filing":"0001618835-21-000135","document":"wf-form4_162162876295987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000135/wf-form4_162162876295987.xml","form_type":"4"}},{"id":2700433,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-05-21T16:26:55.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":42120,"price":0.86,"value":36223.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":301422,"source":{"system":"sec-edgar","filing":"0001618835-21-000137","document":"wf-form4_162162880189777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000137/wf-form4_162162880189777.xml","form_type":"4"}},{"id":2700988,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-21T16:25:59.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":42280,"price":0.86,"value":36360.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":415888,"source":{"system":"sec-edgar","filing":"0001618835-21-000134","document":"wf-form4_162162874189569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883521000134/wf-form4_162162874189569.xml","form_type":"4"}},{"id":2700543,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T16:25:34.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":105300,"price":0.86,"value":90558.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":800837,"source":{"system":"sec-edgar","filing":"0001618835-21-000133","document":"wf-form4_162162870730649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000133/wf-form4_162162870730649.xml","form_type":"4"}},{"id":2713907,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-13T20:15:41.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Dr. Rarick's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000111","document":"wf-form4_162093692202581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000111/wf-form4_162093692202581.xml","form_type":"4"}},{"id":2714027,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-13T20:15:16.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Dr. Kamdar's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000110","document":"wf-form4_162093685845201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000161883521000110/wf-form4_162093685845201.xml","form_type":"4"}},{"id":2713906,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127524,"kind":"person","name":"O'Brien Anthony Stephen","position":1,"cik":"0001726732","reported_name":"O'Brien Anthony Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:14:07.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Mr. O'Brien's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000109","document":"wf-form4_162093682127478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000109/wf-form4_162093682127478.xml","form_type":"4"}},{"id":2714582,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127533,"kind":"person","name":"Greer Gillian","position":1,"cik":"0001726181","reported_name":"Greer Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-13T16:16:55.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Dr. Greer's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000113","document":"wf-form4_162093698608372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726181/000161883521000113/wf-form4_162093698608372.xml","form_type":"4"}},{"id":2714584,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127534,"kind":"person","name":"Rutherford Colin","position":1,"cik":"0001726264","reported_name":"Rutherford Colin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-13T16:16:19.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Mr. Rutherford's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000112","document":"wf-form4_162093695705945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726264/000161883521000112/wf-form4_162093695705945.xml","form_type":"4"}},{"id":2714583,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139452,"kind":"person","name":"Hall William Walmsley","position":1,"cik":"0001726731","reported_name":"Hall William Walmsley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-13T16:13:37.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2021. The option was awarded in connection with Dr. Hall's board and committee services."}],"balance_after":90000,"derivative":{"exercise_price":1.25,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-21-000108","document":"wf-form4_162093677602785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726731/000161883521000108/wf-form4_162093677602785.xml","form_type":"4"}},{"id":2799433,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-09T18:59:38.000Z","date":"2021-03-09","kind":"purchase","acquired":true,"shares":45249,"price":2.28,"value":103167.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":906137,"source":{"system":"sec-edgar","filing":"0001618835-21-000052","document":"wf-form4_161533435338287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000052/wf-form4_161533435338287.xml","form_type":"4"}},{"id":2880720,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-04T01:02:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-21-000013","document":"wf-form4_161240053204351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000013/wf-form4_161240053204351.xml","form_type":"4"}},{"id":2880719,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-04T01:02:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of securities beneficially owned includes 2,800 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on December 15, 2020, the last trading day of the purchase period."}],"balance_after":481852,"source":{"system":"sec-edgar","filing":"0001618835-21-000013","document":"wf-form4_161240053204351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000013/wf-form4_161240053204351.xml","form_type":"4"}},{"id":2880718,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-04T00:54:18.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-21-000007","document":"wf-form4_161240003886283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000007/wf-form4_161240003886283.xml","form_type":"4"}},{"id":2880717,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:54:18.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":315451,"source":{"system":"sec-edgar","filing":"0001618835-21-000007","document":"wf-form4_161240003886283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883521000007/wf-form4_161240003886283.xml","form_type":"4"}},{"id":2881104,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-03T20:05:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":700000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001618835-21-000015","document":"wf-form4_161240068137959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000015/wf-form4_161240068137959.xml","form_type":"4"}},{"id":2881103,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:05:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":860888,"source":{"system":"sec-edgar","filing":"0001618835-21-000015","document":"wf-form4_161240068137959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000015/wf-form4_161240068137959.xml","form_type":"4"}},{"id":2882068,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-03T20:00:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-21-000011","document":"wf-form4_161240037364841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883521000011/wf-form4_161240037364841.xml","form_type":"4"}},{"id":2882067,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:00:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":458168,"source":{"system":"sec-edgar","filing":"0001618835-21-000011","document":"wf-form4_161240037364841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883521000011/wf-form4_161240037364841.xml","form_type":"4"}},{"id":2880943,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2021-02-03T19:57:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-21-000009","document":"wf-form4_161240022820711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000009/wf-form4_161240022820711.xml","form_type":"4"}},{"id":2880942,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-02-03T19:57:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":343542,"source":{"system":"sec-edgar","filing":"0001618835-21-000009","document":"wf-form4_161240022820711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000009/wf-form4_161240022820711.xml","form_type":"4"}},{"id":2975376,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-18T17:22:52.000Z","date":"2020-11-17","kind":"purchase","acquired":true,"shares":7760,"price":2.17,"value":16839.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":258168,"source":{"system":"sec-edgar","filing":"0001618835-20-000248","document":"wf-form4_160573815596283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883520000248/wf-form4_160573815596283.xml","form_type":"4"}},{"id":2974550,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-11-18T17:14:50.000Z","date":"2020-11-17","kind":"purchase","acquired":true,"shares":9090,"price":2.2,"value":19998.0,"ownership":{"direct":true},"balance_after":143542,"source":{"system":"sec-edgar","filing":"0001618835-20-000246","document":"wf-form4_160573767675790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000246/wf-form4_160573767675790.xml","form_type":"4"}},{"id":3032973,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-11T21:20:00.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":3000,"price":2.08,"value":6240.0,"ownership":{"direct":true},"balance_after":279052,"source":{"system":"sec-edgar","filing":"0001618835-20-000220","document":"wf-form4_159985918676264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000220/wf-form4_159985918676264.xml","form_type":"4"}},{"id":3032972,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-11T21:20:00.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":1000,"price":2.71,"value":2710.0,"ownership":{"direct":true},"balance_after":276052,"source":{"system":"sec-edgar","filing":"0001618835-20-000220","document":"wf-form4_159985918676264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000220/wf-form4_159985918676264.xml","form_type":"4"}},{"id":3034196,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-10T20:04:39.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":122500,"price":3.26,"value":399350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.09 to $3.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period."}],"balance_after":360888,"source":{"system":"sec-edgar","filing":"0001618835-20-000218","document":"wf-form4_159978266397349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000218/wf-form4_159978266397349.xml","form_type":"4"}},{"id":3080022,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":106469,"kind":"organization","name":"Link Fund Solutions Ltd","position":1,"cik":"0001792424","reported_name":"Link Fund Solutions Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-07-17T15:11:40.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":9138504,"price":0.23,"value":2101855.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.2608 U.S. Dollars as of June 4, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-019497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000089924320019497/doc4.xml","form_type":"4"}},{"id":3085444,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-09T22:17:13.000Z","date":"2020-07-08","kind":"tax_withholding","acquired":false,"shares":20381,"price":3.3,"value":67257.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 8, 2020. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of securities beneficially owned includes 1,924 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period."}],"balance_after":275052,"source":{"system":"sec-edgar","filing":"0001618835-20-000206","document":"wf-form4_159433301888130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000206/wf-form4_159433301888130.xml","form_type":"4"}},{"id":3105037,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:29:57.000Z","date":"2020-06-17","kind":"purchase","acquired":true,"shares":5250,"price":2.99,"value":15697.5,"ownership":{"direct":true},"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001618835-20-000204","document":"wf-form4_159251217994076.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000204/wf-form4_159251217994076.xml","form_type":"4"}},{"id":3105642,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139452,"kind":"person","name":"Hall William Walmsley","position":1,"cik":"0001726731","reported_name":"Hall William Walmsley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T16:29:37.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":5000,"price":2.85,"value":14250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4, filed on June 17,2020, is being amended to update the price range reported in Column 4 of Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.845 to $2.85, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001618835-20-000203","document":"wf-form4a_159251215883461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726731/000161883520000203/wf-form4a_159251215883461.xml","form_type":"4/A","original_submission_date":"2020-06-17"}},{"id":3107330,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139452,"kind":"person","name":"Hall William Walmsley","position":1,"cik":"0001726731","reported_name":"Hall William Walmsley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T20:38:23.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":5000,"price":2.85,"value":14250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001618835-20-000198","document":"wf-form4_159244068645749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726731/000161883520000198/wf-form4_159244068645749.xml","form_type":"4"}},{"id":3108467,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T20:35:13.000Z","date":"2020-06-12","kind":"purchase","acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"balance_after":9287,"source":{"system":"sec-edgar","filing":"0001618835-20-000196","document":"wf-form4_159233969119430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000161883520000196/wf-form4_159233969119430.xml","form_type":"4"}},{"id":3110632,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-15T16:16:17.000Z","date":"2020-06-12","kind":"purchase","acquired":true,"shares":8500,"price":3.14,"value":26690.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period."}],"balance_after":250408,"source":{"system":"sec-edgar","filing":"0001618835-20-000194","document":"wf-form4_159225215860208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883520000194/wf-form4_159225215860208.xml","form_type":"4"}},{"id":3117471,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":5559,"kind":"organization","name":"ACACIA RESEARCH CORP","symbol":"ACTG","position":1,"cik":"0000934549","reported_name":"ACACIA RESEARCH CORP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-10T01:08:48.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":9138504,"price":3.209,"value":29325459.336,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000902664-20-002335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/934549/000090266420002335/ownership.xml","form_type":"4"}},{"id":3117488,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":125,"kind":"organization","name":"Invesco Ltd.","symbol":"IVZ","position":1,"cik":"0000914208","reported_name":"Invesco Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2020-06-09T10:49:22.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":857143,"price":3.5,"value":3000000.5,"ownership":{"direct":false,"nature":"See Footnotes 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 5, 2020, Invesco Ltd., through its affiliates, the Invesco High Income Fund (UK) and the Invesco Income Fund (UK), purchased 589,302 and 267,841, respectively, of the Issuer's common stock at a price of $3.50 per share as part of the Issuer's registered public offering of 28,500,000 shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Invesco Ltd. is aware that, under Section 16(b) of the Securities and Exchange Act of 1934, as amended, certain of the sales are matachable against certain purchases of Common Stock.  Invesco Ltd. has calculated the aggregate profit to be $174,140.20, using the lowest possible purchase prices and the highest possible sales prices for such trades, and accordingly intends to remit payment to the Company in that amount less transaction costs."}],"balance_after":13226532,"source":{"system":"sec-edgar","filing":"0001209191-20-035184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914208/000120919120035184/doc4.xml","form_type":"4"}},{"id":3117487,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":125,"kind":"organization","name":"Invesco Ltd.","symbol":"IVZ","position":1,"cik":"0000914208","reported_name":"Invesco Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2020-06-09T10:49:22.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":65,"price":5.98,"value":388.7,"ownership":{"direct":false,"nature":"See Footnotes 1"},"balance_after":12369389,"source":{"system":"sec-edgar","filing":"0001209191-20-035184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914208/000120919120035184/doc4.xml","form_type":"4"}},{"id":3117486,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":125,"kind":"organization","name":"Invesco Ltd.","symbol":"IVZ","position":1,"cik":"0000914208","reported_name":"Invesco Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2020-06-09T10:49:22.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":73814,"price":5.79,"value":427383.06,"ownership":{"direct":false,"nature":"See Footnotes 1"},"balance_after":12369454,"source":{"system":"sec-edgar","filing":"0001209191-20-035184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914208/000120919120035184/doc4.xml","form_type":"4"}},{"id":3117485,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":125,"kind":"organization","name":"Invesco Ltd.","symbol":"IVZ","position":1,"cik":"0000914208","reported_name":"Invesco Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2020-06-09T10:49:22.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":3211,"price":5.04,"value":16183.44,"ownership":{"direct":false,"nature":"See Footnotes 1"},"balance_after":12443268,"source":{"system":"sec-edgar","filing":"0001209191-20-035184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914208/000120919120035184/doc4.xml","form_type":"4"}},{"id":3117484,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":125,"kind":"organization","name":"Invesco Ltd.","symbol":"IVZ","position":1,"cik":"0000914208","reported_name":"Invesco Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock","published_at":"2020-06-09T10:49:22.000Z","date":"2020-05-14","kind":"other","acquired":true,"shares":78013,"price":5.13,"value":400206.69,"ownership":{"direct":false,"nature":"See Footnotes 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Invesco Ltd. acquired the following common shares through its affiliates in a spin off transaction (the \"Spin Off Transaction\") on May 14, 2020: Invesco FTSE RAFI US 1500 Small-Mid ETF (73,814 shares of common stock); Invesco Buyback Achievers ETF (3,257 shares of common stock); LongView Broad Market 3000 Index Fund (Amalgamated) (923 shares of common stock); and Invesco Purebeta MSCI USA Small Cap ETF (19 shares of common stock).  On May 15, 2020 the Invesco Buyback Achievers ETF sold 3,211 shares of Common Stock.  On May 26, 2020, the Invesco FTSE RAFI US 1500 Small-Mid ETF sold 73,814 shares of Common Stock, the Invesco Buyback Achievers ETF sold 46 shares of Common Stock and the Invesco Purebeta MSCI USA Small Cap ETF sold 19 shares."}],"balance_after":12446479,"source":{"system":"sec-edgar","filing":"0001209191-20-035184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914208/000120919120035184/doc4.xml","form_type":"4"}},{"id":3118098,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-08T21:43:00.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":31548,"price":3.31,"value":104423.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":115451,"source":{"system":"sec-edgar","filing":"0001618835-20-000188","document":"wf-form4_159165256285979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000188/wf-form4_159165256285979.xml","form_type":"4"}},{"id":3118097,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-08T21:42:17.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":15455,"price":3.31,"value":51156.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":293509,"source":{"system":"sec-edgar","filing":"0001618835-20-000186","document":"wf-form4_159165251807510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000186/wf-form4_159165251807510.xml","form_type":"4"}},{"id":3118860,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-08T17:43:23.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":42810,"price":3.31,"value":141701.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":237605,"source":{"system":"sec-edgar","filing":"0001618835-20-000189","document":"wf-form4_159165258593749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883520000189/wf-form4_159165258593749.xml","form_type":"4"}},{"id":3118326,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-08T17:42:38.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":85620,"price":3.31,"value":283402.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":479085,"source":{"system":"sec-edgar","filing":"0001618835-20-000187","document":"wf-form4_159165254089208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000187/wf-form4_159165254089208.xml","form_type":"4"}},{"id":3118200,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-06-08T17:41:53.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":31590,"price":3.31,"value":104562.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":134452,"source":{"system":"sec-edgar","filing":"0001618835-20-000185","document":"wf-form4_159165249625617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000185/wf-form4_159165249625617.xml","form_type":"4"}},{"id":3134656,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-26T21:16:29.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":39435,"price":4.99,"value":196780.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":146999,"source":{"system":"sec-edgar","filing":"0001618835-20-000157","document":"wf-form4_159052777118613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000157/wf-form4_159052777118613.xml","form_type":"4"}},{"id":3134655,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-26T21:16:05.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":19474,"price":4.99,"value":97175.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":308964,"source":{"system":"sec-edgar","filing":"0001618835-20-000156","document":"wf-form4_159052774810234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000156/wf-form4_159052774810234.xml","form_type":"4"}},{"id":3135901,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI","position":1,"cik":"0000882104","reported_name":"PDL BIOPHARMA, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T20:43:05.000Z","date":"2020-05-21","kind":"other","acquired":false,"shares":13333334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution in-kind of the shares formerly held by the Reporting Person to its stockholders for no consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-014185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000089924320014185/doc4.xml","form_type":"4"}},{"id":3134876,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-26T17:17:15.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":84525,"price":4.99,"value":421779.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":564705,"source":{"system":"sec-edgar","filing":"0001618835-20-000159","document":"wf-form4_159052781756168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000159/wf-form4_159052781756168.xml","form_type":"4"}},{"id":3134764,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-05-26T17:16:54.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":39487,"price":4.99,"value":197040.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":166042,"source":{"system":"sec-edgar","filing":"0001618835-20-000158","document":"wf-form4_159052779414010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000158/wf-form4_159052779414010.xml","form_type":"4"}},{"id":3135284,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-26T17:15:42.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":42262,"price":4.99,"value":210887.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":280415,"source":{"system":"sec-edgar","filing":"0001618835-20-000155","document":"wf-form4_159052772480668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883520000155/wf-form4_159052772480668.xml","form_type":"4"}},{"id":3150237,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127524,"kind":"person","name":"O'Brien Anthony Stephen","position":1,"cik":"0001726732","reported_name":"O'Brien Anthony Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T20:40:34.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Mr. O'Brien's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000137","document":"wf-form4_158940241739274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000137/wf-form4_158940241739274.xml","form_type":"4"}},{"id":3150236,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-05-13T20:39:52.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Dr. Rarick's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000135","document":"wf-form4_158940237371677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000135/wf-form4_158940237371677.xml","form_type":"4"}},{"id":3150299,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":1,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-05-13T20:39:25.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Dr. Kamdar's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000134","document":"wf-form4_158940234764353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535065/000161883520000134/wf-form4_158940234764353.xml","form_type":"4"}},{"id":3151032,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127534,"kind":"person","name":"Rutherford Colin","position":1,"cik":"0001726264","reported_name":"Rutherford Colin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-05-13T16:40:57.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Mr. Rutherford's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000138","document":"wf-form4_158940243940813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726264/000161883520000138/wf-form4_158940243940813.xml","form_type":"4"}},{"id":3151030,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127533,"kind":"person","name":"Greer Gillian","position":1,"cik":"0001726181","reported_name":"Greer Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-05-13T16:40:12.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Dr. Greer's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000136","document":"wf-form4_158940239482771.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726181/000161883520000136/wf-form4_158940239482771.xml","form_type":"4"}},{"id":3151031,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139452,"kind":"person","name":"Hall William Walmsley","position":1,"cik":"0001726731","reported_name":"Hall William Walmsley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-05-13T16:39:04.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 12, 2020. The option was awarded in connection with Dr. Hall's board and committee services."}],"balance_after":50000,"derivative":{"exercise_price":5.06,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001618835-20-000133","document":"wf-form4_158940232263709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726731/000161883520000133/wf-form4_158940232263709.xml","form_type":"4"}},{"id":3156067,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-08T16:32:22.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":3802,"price":5.24,"value":19922.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":328438,"source":{"system":"sec-edgar","filing":"0001618835-20-000115","document":"wf-form4_158895552459899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000115/wf-form4_158895552459899.xml","form_type":"4"}},{"id":3155963,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-08T16:31:56.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":7792,"price":5.24,"value":40830.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":186434,"source":{"system":"sec-edgar","filing":"0001618835-20-000114","document":"wf-form4_158895549907652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000114/wf-form4_158895549907652.xml","form_type":"4"}},{"id":3156592,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":66715,"kind":"person","name":"File Justin J.","position":1,"cik":"0001726277","reported_name":"File Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-08T12:31:36.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":8420,"price":5.24,"value":44120.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":322677,"source":{"system":"sec-edgar","filing":"0001618835-20-000113","document":"wf-form4_158895547746701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726277/000161883520000113/wf-form4_158895547746701.xml","form_type":"4"}},{"id":3156100,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-08T12:31:11.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":16905,"price":5.24,"value":88582.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":649230,"source":{"system":"sec-edgar","filing":"0001618835-20-000112","document":"wf-form4_158895545390049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000112/wf-form4_158895545390049.xml","form_type":"4"}},{"id":3156047,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-05-08T12:30:50.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":7802,"price":5.24,"value":40882.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":205529,"source":{"system":"sec-edgar","filing":"0001618835-20-000111","document":"wf-form4_158895543229158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000111/wf-form4_158895543229158.xml","form_type":"4"}},{"id":3165000,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-02T00:12:48.000Z","date":"2020-05-01","kind":"sale","acquired":false,"shares":1000,"price":4.75,"value":4750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019."}],"balance_after":194226,"source":{"system":"sec-edgar","filing":"0001618835-20-000096","document":"wf-form4_158837835074185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000096/wf-form4_158837835074185.xml","form_type":"4"}},{"id":3164999,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-02T00:12:48.000Z","date":"2020-04-30","kind":"sale","acquired":false,"shares":1000,"price":4.66,"value":4660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019."}],"balance_after":195226,"source":{"system":"sec-edgar","filing":"0001618835-20-000096","document":"wf-form4_158837835074185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000096/wf-form4_158837835074185.xml","form_type":"4"}},{"id":3188813,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":150162,"kind":"person","name":"Lynch Thomas G","position":1,"cik":"0001360000","reported_name":"Lynch Thomas G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-01T16:11:24.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services to be provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer effective April 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal installments on June 30, 2020, September 30, 2020, December 31, 2020 and March 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal installments on June 30, 2020, September 30, 2020, December 31, 2020 and March 31, 2021."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-20-000073","document":"wf-form4_158577186560857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1360000/000161883520000073/wf-form4_158577186560857.xml","form_type":"4"}},{"id":3188812,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":150162,"kind":"person","name":"Lynch Thomas G","position":1,"cik":"0001360000","reported_name":"Lynch Thomas G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-01T16:11:24.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services to be provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer effective April 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal installments on June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal installments on June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001618835-20-000073","document":"wf-form4_158577186560857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1360000/000161883520000073/wf-form4_158577186560857.xml","form_type":"4"}},{"id":3188811,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":150162,"kind":"person","name":"Lynch Thomas G","position":1,"cik":"0001360000","reported_name":"Lynch Thomas G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-01T16:11:24.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services to be provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer effective April 1, 2019."}],"balance_after":325000,"source":{"system":"sec-edgar","filing":"0001618835-20-000073","document":"wf-form4_158577186560857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1360000/000161883520000073/wf-form4_158577186560857.xml","form_type":"4"}},{"id":3245700,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":127523,"kind":"person","name":"Rarick Lisa Dale","position":1,"cik":"0001803550","reported_name":"Rarick Lisa Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-27T01:22:18.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest on a monthly basis over 3 years upon completion of continuous service for the Issuer from the vesting commencement date of February 25, 2020. The option was awarded in connection with Dr. Rarick's appointment to the Issuer's Board of Directors."}],"balance_after":75000,"derivative":{"exercise_price":5.85,"expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001618835-20-000037","document":"wf-form4_158276652169035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000037/wf-form4_158276652169035.xml","form_type":"4"}},{"id":3255708,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":139136,"kind":"person","name":"Culwell Kelly","position":1,"cik":"0001726183","reported_name":"Culwell Kelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-21T19:10:42.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":1000,"price":7,"value":7000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019."}],"balance_after":196226,"source":{"system":"sec-edgar","filing":"0001618835-20-000028","document":"wf-form4_158231222323693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000028/wf-form4_158231222323693.xml","form_type":"4"}},{"id":3255706,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":137439,"kind":"person","name":"Barrans Russell","position":1,"cik":"0001726184","reported_name":"Barrans Russell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-02-21T19:10:19.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":14957,"price":6.5,"value":97220.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019."}],"balance_after":332240,"source":{"system":"sec-edgar","filing":"0001618835-20-000027","document":"wf-form4_158231220248237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883520000027/wf-form4_158231220248237.xml","form_type":"4"}}],"next_cursor":"2020-02-21T19:10:19.000000Z,3255706"}